LYTIX BIOPHARMA ASA

Operating

Home - Lytix Biopharma

Utvikling, markedsføring og salg av farmasøytiske og bioteknologiske produkter, samt dertil hørende virksomhet. Selskapet kan ha eierinteresser i foretak innen samme eller tilstøtende bransjer.

Utvikling av produkter for salg eller lisensiering til større legemiddelfirmaer inne kreft eller infeksjonsterapi.

Organization

CEO: ØR
Øystein Rekdal1962
Chairman of the board: EM
Eric Michel Falcand1962
Years since formation: 23 years; since Aug 25, 2003
Type: Public limited company
VAT registered: Yes
Number of employees: 9

Ownership

Number of shares and share classes: 68,262,002; 1 share class
Total number of shareholders: 1376; 266 companies, 1,110 persons

Financials

Annual total result 2025: -59,982,000; NOK
Total equity 2025: 61,750,000; NOK

Last update: Oct 13, 2026

Management

Management / administration

Name	Role	Shares
ØR Øystein Rekdal 1962	Managing Director/CEO	-

Board

Name	Role	Shares
EM Eric Michel Falcand 1962	Chairman	-
BK Brynjar Kristian Forbergskog 1958	Board Member	-
HM Helena Marie-Louise Fjällskog 1964	Board Member	-
JH Julie Helene Madeleine Dehaene 1973	Board Member	-
CA Claus Asbjørn Andersson 1968	Board Member	-
DM Darlene M Deptula-Hicks 1957	Board Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
E ENORA AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
FJ Forbergskog Jens-Otto 1987	-	4.16 % indirectly
KF Kristian Forbergskog Brynjar 1958	-	3.29 % indirectly
NY Nilssen Yngvar 1986	-	2.64 % indirectly
AJ Arnulf Johansen Terje 1955	-	2.57 % directly 0.15 % indirectly 2.43 %
NO Nergård Ole-Kristian 1992	-	2.03 % indirectly
GP Grieg Per 1957	-	1.92 % indirectly
TH Therese Hansen Linda 1983	-	1.81 % indirectly
HT Hatteland Tommy 1990	-	1.45 % indirectly
HR Hatteland Randi 1978	-	1.45 % indirectly
HS Hatteland Stig 1980	-	1.45 % indirectly

Last update: Apr 16, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
J JAKOB HATTELAND HOLDING AS	Ordinary shares	6,895,190	10.1 %
T TAJ HOLDING AS	Ordinary shares	4,496,593	6.59 %
S SATURN INVEST AS	Ordinary shares	4,485,579	6.57 %
L LYR INVEST AS	Ordinary shares	2,438,863	3.57 %
B BRØDRENE KARLSEN HOLDING AS	Ordinary shares	2,283,507	3.35 %
P PER STRAND EIENDOM AS	Ordinary shares	2,019,102	2.96 %
3 3T PRODUKTER HOLDING AS	Ordinary shares	1,808,764	2.65 %
L LYSNES INVEST AS	Ordinary shares	1,448,987	2.12 %
N NORDNET LIVSFORSIKRING AS	Ordinary shares	1,447,701	2.12 %
Y YNNI INVEST AS	Ordinary shares	1,392,889	2.04 %
H HIFO INVEST AS	Ordinary shares	1,318,913	1.93 %
K KVASSHØGDI AS	Ordinary shares	1,307,652	1.92 %
L LTH INVEST AS	Ordinary shares	896,786	1.31 %
B BELVEDERE AS	Ordinary shares	892,292	1.31 %
D DRAGESUND INVEST AS	Ordinary shares	685,436	1 %
OL Ove Løkke Pettersen Per 1985	Ordinary shares	620,400	0.91 %
VA Vohra Arun 1974	Ordinary shares	620,000	0.91 %
C CARE HOLDING AS	Ordinary shares	606,512	0.89 %
J JPB AS	Ordinary shares	590,839	0.87 %
N NORINNOVA INVEST AS	Ordinary shares	527,064	0.77 %
S SPARLI AS	Ordinary shares	492,194	0.72 %
H HOPEN INVEST AS	Ordinary shares	481,117	0.7 %
H HERSETH AS	Ordinary shares	461,500	0.68 %
H HARILA INVEST AS	Ordinary shares	461,350	0.68 %
WB Wiggo Berger Kai 1946	Ordinary shares	403,000	0.59 %
K KNUT FOSSE AS	Ordinary shares	397,816	0.58 %
L LUKAS I AS	Ordinary shares	395,000	0.58 %
N NEW LINK AS	Ordinary shares	350,000	0.51 %
BE Billington Erik 1974	Ordinary shares	333,333	0.49 %
KB Kroknes Brynjar 1961	Ordinary shares	329,089	0.48 %
ØG Øye Gunnar 1965	Ordinary shares	255,500	0.37 %
T TUT AS	Ordinary shares	240,000	0.35 %
H HUMAT AS	Ordinary shares	227,301	0.33 %
J JESEM AS	Ordinary shares	225,000	0.33 %
K KREFTFORENINGEN	Ordinary shares	218,000	0.32 %
S SALTHAVN AS	Ordinary shares	211,111	0.31 %
T TRIM INVEST AS	Ordinary shares	206,000	0.3 %
S STEIN TORE GUSTAVSEN AS	Ordinary shares	203,008	0.3 %
F FREWI AS	Ordinary shares	200,010	0.29 %
ED Erik Damsgård Alf 1958	Ordinary shares	200,000	0.29 %
D DR. RABIB HOLDING AS	Ordinary shares	198,296	0.29 %
T TAVE INVEST AS	Ordinary shares	185,000	0.27 %
RØ Rekdal Øystein 1962	Ordinary shares	176,179	0.26 %
J JTT AS	Ordinary shares	171,249	0.25 %
E EWS STIFTELSEN	Ordinary shares	170,815	0.25 %
B BYGGETUN EIENDOM AS	Ordinary shares	169,959	0.25 %
H HEYERN AS	Ordinary shares	167,230	0.24 %
F FM HOLDING AS	Ordinary shares	166,666	0.24 %
N NYHAMN AS	Ordinary shares	166,666	0.24 %
C CLOUD HOLDING AS	Ordinary shares	163,155	0.24 %
EW Eyvin Wang Jan 1956	Ordinary shares	160,831	0.24 %
4 4 LB INVEST AS	Ordinary shares	160,040	0.23 %
N NORINNOVA AS	Ordinary shares	155,790	0.23 %
S SEAFOOD HOLDING AS	Ordinary shares	155,093	0.23 %
P PHARMAPATENT AS	Ordinary shares	152,420	0.22 %
S SPAREBANK 1 NORD-NORGE PORTEFØLJE AS	Ordinary shares	151,820	0.22 %
FE Figenschou Eriksen Jon 1946	Ordinary shares	150,000	0.22 %
TF Terje Fagerbakke John 1968	Ordinary shares	150,000	0.22 %
T TANANGER HOLDING AS	Ordinary shares	140,000	0.21 %
A AGIR AS	Ordinary shares	137,864	0.2 %
MJ Morten Johnsen Harald 1960	Ordinary shares	135,000	0.2 %
O OMLAND INVESTMENTS AS	Ordinary shares	133,866	0.2 %
EA Eugen Aschim Terje 1954	Ordinary shares	131,000	0.19 %
C COUSI INVEST AS	Ordinary shares	130,132	0.19 %
MA Magnus Albertsen Øystein 1956	Ordinary shares	130,000	0.19 %
S SPIRALEN HOLDING AS	Ordinary shares	125,000	0.18 %
IM Iversen Marius 1983	Ordinary shares	118,000	0.17 %
B BGB INVEST AS	Ordinary shares	118,000	0.17 %
B BLOKMAR AS	Ordinary shares	111,235	0.16 %
RE Rosen Erik 1964	Ordinary shares	109,715	0.16 %
K KRÆMER AS	Ordinary shares	108,000	0.16 %
M MIKINVEST AS	Ordinary shares	106,545	0.16 %
Ø ØKSNES INVEST AS	Ordinary shares	106,180	0.16 %
KS Karol Staskiewicz Krzysztof 1980	Ordinary shares	100,273	0.15 %
S SØRLIA HOLDING AS	Ordinary shares	100,000	0.15 %
IT Ingvald Tvenge Torstein 1952	Ordinary shares	100,000	0.15 %
L LARK AS	Ordinary shares	100,000	0.15 %
AJ Arnulf Johansen Terje 1955	Ordinary shares	100,000	0.15 %
E ELHATT AS	Ordinary shares	100,000	0.15 %
I ISTI AS	Ordinary shares	100,000	0.15 %
A AMFIBIEN AS	Ordinary shares	94,536	0.14 %
T TROMS KRAFT AS	Ordinary shares	93,730	0.14 %
D DRØNEN EIENDOM AS	Ordinary shares	93,527	0.14 %
P POLARFJELLFLOKK AS	Ordinary shares	93,112	0.14 %
E ETRADE ARCTIC AS	Ordinary shares	91,190	0.13 %
KA Kleppe Atle 1966	Ordinary shares	86,459	0.13 %
M MOTOR TRADE EIENDOM OG FINANS AS	Ordinary shares	84,966	0.12 %
E ENTREPRENØR-DIREKTØR'N HOLDING AS	Ordinary shares	83,109	0.12 %
ON Oddvar Nygård Frank 1976	Ordinary shares	80,107	0.12 %
GD Gunnar Dahle Lars 1955	Ordinary shares	80,000	0.12 %
IO Ingebretsen Otto 1954	Ordinary shares	80,000	0.12 %
D DR. RABIB HELSETJENESTE AS	Ordinary shares	79,500	0.12 %
B BAI AS	Ordinary shares	75,000	0.11 %
H HØSE AS	Ordinary shares	74,530	0.11 %
M MOBITAG AS	Ordinary shares	73,900	0.11 %
RD Rabib David 1973	Ordinary shares	70,000	0.1 %
BI Byrkjedal Ivar 1977	Ordinary shares	70,000	0.1 %
ØB Ødegård Bjorbekk Rune 1970	Ordinary shares	70,000	0.1 %
W WORKPARTNER AS	Ordinary shares	68,500	0.1 %
M MYRBAKK EIENDOM AS	Ordinary shares	67,860	0.1 %

Last update: Sep 25, 2026

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	0	11,134,000	3,991,213	17,273,000	25,827,000
Annual Total Result	-59,982,000	-94,265,000	-87,897,449	-56,007,000	-48,048,000
Total assets	81,524,000	146,535,000	63,874,065	152,017,000	202,962,000
Total liabilities	19,774,000	38,642,000	12,554,758	16,891,000	13,338,000
Total equity	61,750,000	107,894,000	51,319,307	135,126,000	189,624,000

P&L

Year	2025	2024	2023	2022	2021
Total operating income	0	11,134,000	3,991,213	17,273,000	25,827,000
Total operating costs	64,028,000	107,029,000	100,775,794	82,969,000	73,843,000
Operating result	-64,028,000	-95,896,000	-96,784,582	-65,696,000	-48,016,000
Financial income/costs	4,046,000	1,631,000	8,887,133	9,689,000	-32,000
Profit before tax	-59,982,000	-94,265,000	-87,897,449	-56,007,000	-48,048,000
Total tax & extraordinary income/cost	0	0	0	0	0
Annual Total Result	-59,982,000	-94,265,000	-87,897,449	-56,007,000	-48,048,000

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	2,087,000	2,631,000	548,491	124,000	0
Total current assets	79,436,000	143,904,000	63,325,574	151,893,000	202,962,000
Total assets	81,524,000	146,535,000	63,874,065	152,017,000	202,962,000
Short term debt	18,552,000	36,764,000	12,514,171	16,891,000	13,338,000
Long term debt	1,222,000	1,878,000	40,587	0	0
Total liabilities	19,774,000	38,642,000	12,554,758	16,891,000	13,338,000
Contributed capital	61,750,000	107,894,000	51,319,307	135,126,000	189,624,000
Retained earnings	0	0	0	0	0
Total equity	61,750,000	107,894,000	51,319,307	135,126,000	189,624,000
Total equity and liabilities	81,524,000	146,535,000	63,874,065	152,017,000	202,962,000

Classification

21st company classification

BETA

Small company

Type of organization

Public limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

LYTIX BIOPHARMA ASA985 889 635